Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NASDAQ:EXAC

Exactech (EXAC) Stock Price, News & Analysis

Exactech logo

About Exactech Stock (NASDAQ:EXAC)

Advanced Chart

Key Stats

Today's Range
$49.25
$49.30
50-Day Range
N/A
52-Week Range
$23.75
$50.95
Volume
255,640 shs
Average Volume
182,742 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Exactech, Inc. develops, manufactures, markets, distributes and sells orthopedic implant devices, related surgical instrumentation and biologic services to hospitals and physicians. The Company's segments include knee, hip, biologics and spine, extremity and other products. Its other products segment includes miscellaneous sales categories, such as bone cement, instrument rental fees, shipping charges and other product lines. The Company distributes joint replacement systems, including knee, hip, spine and extremity implant systems, and biologic products and services and bone cement materials used in orthopedic surgery and dental procedures. The Exactech Knee System provides solutions for partial, primary and revision total knee arthroplasty. Its hip solutions address the continuum of hip arthroplasty. It manufactures and distributes various products and services designed for the healing and regeneration of bone and soft tissue, including products, which contain human allograft.

Receive EXAC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Exactech and its competitors with MarketBeat's FREE daily newsletter.

EXAC Stock News Headlines

Missed Tesla? Don’t Miss Elon's Next Big Move
I believe Elon's next venture, his "Final Move," could mint more millionaires than any project he's ever been a part of before.
See More Headlines

EXAC Stock Analysis - Frequently Asked Questions

Exactech Inc (NASDAQ:EXAC) released its quarterly earnings results on Monday, October, 30th. The medical equipment provider reported $0.20 earnings per share for the quarter, missing analysts' consensus estimates of $0.23 by $0.03. The medical equipment provider earned $61.40 million during the quarter, compared to the consensus estimate of $61.78 million.

Based on aggregate information from My MarketBeat watchlists, some other companies that Exactech investors own include Immersion (IMMR), Verizon Communications (VZ), Bristol-Myers Squibb (BMY), Johnson & Johnson (JNJ), Meta Platforms (META), Riot Platforms (RIOT) and Allergan (AGN).

Company Calendar

Last Earnings
10/30/2017
Today
1/18/2025

Industry, Sector and Symbol

Sector
N/A
Industry
N/A
Sub-Industry
Health Care Equipment
Current Symbol
NASDAQ:EXAC
CUSIP
30064E10
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

This page (NASDAQ:EXAC) was last updated on 1/18/2025 by MarketBeat.com Staff
From Our Partners